Snapshot from Aug 24, 2026 at 07:00 UTC. For live data and tracking: View Live
Person

Richard Adcock

Tracked across 2 events · 196 articles · First seen Apr 01, 2026 · Last active May 28, 2026

Sentiment
-25
Attention
4
Events
2
Relationships
10
Live sentiment trends, attention charts, and prominence tracking available on the Ergen Dashboard
4 -50
Regulatory
Impact: Richard Adcock is the CEO of ImmunityBio and was the recipient of the FDA's warning letter regarding the misleading promotion of Nogapendekin alfa inbakicept.
Apr 02, 2026 · 132 articles
4 0
Business
Apr 01, 2026 · 64 articles
Patrick Soon-Shiong Richard Adcock
Patrick Soon-Shiong Richard Adcock
ImmunityBio Richard Adcock
ImmunityBio Richard Adcock
Kahn Swick & Foti Richard Adcock
Kahn Swick & Foti Richard Adcock
Hagens Berman Richard Adcock
Hagens Berman Richard Adcock
ERGEN INTELLIGENCE
Track Richard Adcock live

Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.

Open Dashboard

About Ergen

Ergen is a news intelligence platform that converts raw news articles into structured data. It tracks events, entities, and the relationships between them, with sentiment and attention metrics derived from thousands of articles. Pages on this site are daily static snapshots from the platform's live database. For real-time tracking, search, and alerts, the full dashboard is at app.ergen.ai.